Can DaVita Stock Continue Its Bull Run After Doubling in a Year?

Shares of DaVita (DVA) have risen 115.5% in the past year, outperforming the Zacks Medical - Outpatient and Home Healthcare industry's growth of 37.8% and the broader Zacks Medical sector's return of 12.3%. The strong bull run in the DVA stock was primarily due to rising demand for its dialysis services, following the disruption of demand amid COVID-19. The upward trend is expected to persist through the remainder of 2024 and beyond, driven by increasing demand for dialysis services due to a growing number ...